当前位置:首页 - 行情中心 - 睿智医药(300149) - 财务分析 - 资产负债表

睿智医药

(300149)

  

流通市值:34.07亿  总市值:34.13亿
流通股本:4.99亿   总股本:5.00亿

资产负债表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
流动资产:
货币资金319,420,527.01317,152,014.39331,046,367.03347,259,606.5
应收票据及应收账款203,009,214.4190,427,409.77234,103,763.64263,852,545.51
应收账款203,009,214.4190,427,409.77234,103,763.64263,852,545.51
预付款项14,856,493.0412,607,728.056,887,138.9210,342,934.82
其他应收款合计12,618,212.7111,755,470.3817,362,357.4512,010,653.41
存货10,282,754.9717,178,783.8420,833,132.1227,882,102.21
合同资产12,713,262.586,741,245.347,365,099.024,254,346.16
一年内到期的非流动资产343,838.54349,697.25347,533.36347,533.36
其他流动资产48,364,856.2557,510,093.2856,988,039.7659,023,714.47
流动资产平衡项目0000
流动资产合计623,951,592615,056,179.17676,526,244.27727,179,070.94
非流动资产:
长期股权投资203,472,804.25200,483,067.36199,329,451.61197,494,208.01
其他非流动金融资产2,296,5002,296,5002,296,5002,296,500
投资性房地产73,969,332.0776,199,280.4278,103,251.9479,212,318.12
固定资产349,468,721.41355,599,248.77366,646,718.61373,935,752.78
在建工程12,811,848.6311,082,554.327,518,946.927,962,682.98
使用权资产354,250,340.43430,840,575.2450,162,025.55469,490,716.35
无形资产29,976,412.0630,565,997.4231,155,582.7630,047,608.03
商誉139,260,380.19139,260,380.19139,260,380.19139,260,380.19
长期待摊费用282,348,456.99302,883,975.02313,922,147.45324,355,752.21
递延所得税资产39,005,506.1746,314,266.7140,061,278.640,446,033
其他非流动资产45,836,633.844,266,015.3341,431,635.2442,641,907.51
非流动资产平衡项目0000
非流动资产合计1,532,696,9361,639,791,860.741,669,887,918.871,707,143,859.18
资产平衡项目0000
资产总计2,156,648,5282,254,848,039.912,346,414,163.142,434,322,930.12
流动负债:
短期借款28,454,722.2238,468,888.8964,300,777.7860,002,611.08
应付票据及应付账款47,723,120.5543,471,258.935,805,001.4153,792,037.91
应付账款47,723,120.5543,471,258.935,805,001.4153,792,037.91
合同负债57,451,407.4455,519,373.2460,079,350.0973,239,572.9
应付职工薪酬40,232,401.6954,884,267.7561,923,197.0357,616,415.66
应交税费4,994,324.185,203,145.943,949,087.758,461,058.16
其他应付款合计101,178,995.2579,980,887.884,774,044.8898,709,481.71
一年内到期的非流动负债67,157,268.0782,693,169.9473,669,116.4173,932,423.45
其他流动负债34,640.18243,101.3431,047.511,021,144.89
流动负债平衡项目0000
流动负债合计347,226,879.58360,464,093.76384,931,622.86426,774,745.76
非流动负债:
长期借款40,414,91640,414,91643,674,91643,674,916
租赁负债346,658,823417,489,786.97438,450,700.72457,730,352.76
预计负债5,412,958.345,355,642.415,298,933.375,242,824.8
递延收益23,396,866.3724,944,659.2626,486,65527,433,414.06
递延所得税负债3,868,766.819,418,336.4210,309,538.3712,581,068.74
非流动负债平衡项目0000
非流动负债合计419,752,330.52497,623,341.06524,220,743.46546,662,576.36
负债平衡项目0000
负债合计766,979,210.1858,087,434.82909,152,366.32973,437,322.12
所有者权益(或股东权益):
实收资本(或股本)499,776,892499,776,892499,776,892499,776,892
资本公积1,229,187,219.211,229,187,219.211,229,187,219.211,229,187,219.21
减:库存股25,506,290.2425,506,290.2425,506,290.2425,506,290.24
其他综合收益8,202,184.2616,491,324.0619,512,064.5717,636,124.87
盈余公积169,649,539.17169,649,539.17169,649,539.17169,649,539.17
未分配利润-515,763,893.51-517,003,377.89-479,557,435.81-454,096,885.15
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计1,365,545,650.891,372,595,306.311,413,061,988.91,436,646,599.86
少数股东权益24,123,667.0124,165,298.7824,199,807.9224,239,008.14
股东权益平衡项目0000
股东权益合计1,389,669,317.91,396,760,605.091,437,261,796.821,460,885,608
负债和股东权益合计2,156,648,5282,254,848,039.912,346,414,163.142,434,322,930.12
公告日期2024-10-302024-08-302024-04-262024-04-26
审计意见(境内)标准无保留意见
TOP↑